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TO THE EDITOR
Filaggrin (filament-aggregating protein)
is a major structural component of the
cornified envelope, which is crucial for
formation of the stratum corneum (SC)
barrier. It is synthesized as a large
precursor, which is stored in the kerato-
hyalin granules in the granular layer.
Upon cornification, filaggrin units are
generated by proteolysis and released to
promote aggregation of keratin inter-
mediate filaments into macrofibrils (re-
viewed in Brown and McLean, 2012).
During the final cornification steps,
filaggrin is degraded into single amino
acids by several enzymes. These hygro-
scopic amino acids, together with their
derivatives, are the main components of
the natural moisturizing factors (NMFs)
needed for hydration of the SC (Scott
et al., 1982). We have shown that
caspase-14, a unique member of the
caspase protease family, can directly
cleave the filaggrin monomer in vitro
(Hoste et al., 2011). Moreover, caspase-
14-deficient mice accumulate incom-
plete filaggrin breakdown products with-
in the SC, leading to reduced levels of
NMF and lower SC hydration (Hoste
et al., 2011). In addition, transepidermal
water loss is increased in these mice,
which are also sensitized to UVB photo-
damage (Denecker et al., 2007).
An important component of the
NMFs is trans-urocanic acid (trans-
UCA), a product of histidine deimina-
tion by the enzyme histidase. Trans-
UCA acts as a major chromophore in
the skin and is converted by UVB to cis-
UCA, which has immunomodulatory
functions (Gibbs et al., 2008). We
hypothesized that the increase in UVB-
induced photodamage in caspase-14-
deficient mice is the consequence of
lower levels of trans-UCA in the SC of
these mice compared with wild type.
This hypothesis is supported by two
recent findings: (1) knockdown of filag-
grin in a human skin model leads to
Abbreviations: AD, atopic dermatitis; CPD, cyclobutane pyrimidine dimer; filaggrin, filament-aggregating
protein; NMF, natural moisturizing factor; OVA, ovalbumin; SC, stratum corneum;
trans-UCA, trans-urocanic acid
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decreased trans-UCA levels and in-
creased UVB-induced DNA damage
resulting in apoptosis (Mildner et al.,
2010), and (2) histidinemic mice, which
have decreased levels of UCA due to
lack of functional histidase, are more
sensitive to UVB irradiation than control
mice, and this increased sensitivity can
be reversed by topical application of
trans-UCA (Barresi et al., 2011).
To test our hypothesis, we exposed
the ex vivo back skin of newborn
caspase-14-deficient and wild-type mice
to UVB, with and without topical
application of exogenous trans-UCA.
We used a cyclobutane pyrimidine
dimer (CPD) ELISA as a quantitative
read-out for UVB photodamage (Barresi
et al., 2011). Upon UVB irradiation, the
amount of CPD in caspase-14-deficient
skin was increased twofold compared
with wild-type skin (Figure 1), confirm-
ing previous observations (Denecker
et al., 2007). Interestingly, topical
trans-UCA application reduced the ele-
vated CPD levels in caspase-14-defi-
cient skin to the levels observed in wild-
type skin (Figure 1), whereas application
of vehicle control had no effect on the
UVB sensitivity. We could not observe a
protective effect of UCA application on
wild-type skin, probably indicating that
in wild-type skin, the UCA levels in the
cornifying layers are already sufficiently
high. Therefore, our data strongly sug-
gest that the loss of filaggrin-derived
trans-UCA is responsible for the in-
creased UVB photodamage in caspase-
14-deficient mice (Denecker et al.,
2007; Hoste et al., 2011). Why there is
a protective effect against UVB photo-
damage of UCA application in the wild-
type mice in the Baressi study (Barresi
et al., 2011) and not in our study is not
clear, but is most likely due to differ-
ences in experimental conditions (UCA
application, UV source, mouse strain).
Numerous genetic association stu-
dies have shown that loss-of-function
mutations in the filaggrin gene (carried
by about 10% of the European popula-
tion) cause the skin-keratinizing disorder
ichthyosis vulgaris, and are major pre-
disposing factors for atopic dermatitis
(AD) and secondary allergies such as
asthma (reviewed in Brown and
McLean, 2012). This led to wide accep-
tance of the outside–inside paradigm of
a primary barrier malfunction preceding
inflammatory reactions by sustained inva-
sion of allergens in filaggrin-linked AD
(Elias et al., 2008). However, it is not clear
whether lower amounts of NMF contri-
bute to AD predisposition. The fact that
flaky tail (ft/ft) mice, which lack functional
filaggrin, develop spontaneous skin in-
flammation, whereas caspase-14-deficient
mice do not, could indicate the impor-
tance of a functional filaggrin monomer in
keeping out inflammatory triggers (Fallon
et al., 2009; Oyoshi et al., 2009;
Scharschmidt et al., 2009). Although
decreased NMF levels are clearly asso-
ciated with AD, it is not known whether
this decrease is a cause or a consequence
of AD (Kezic et al., 2011).
As allergen exposure exacerbates
skin inflammation in ft/ft mice but not
in wild-type mice (Fallon et al., 2009;
Oyoshi et al., 2009), we tested whether
it also exacerbates inflammation in
caspase-14-deficient mice. We used a
well-accepted model of inflammatory
dermatosis, with immunological fea-
tures of AD, involving repeated epicu-
taneous sensitizations with ovalbumin
(OVA; Spergel et al., 1998). Skin
removed from the site of allergen
challenge showed a threefold increase
in epidermal thickness in both caspase-
14-deficient and wild-type mice rela-
tive to phosphate-buffered saline–-
treated animals (Figure 2a and b). In
addition, upon treatment with OVA, the
two genotypes showed similar total IgE
serum levels and similar increases in
mRNA levels of several cytokines: IL-4,
IL-13 (Th2); IFN-g (Th1); IL-17 (Th17);
IL-1b (inflammatory); IL-10 (regulatory;
Figure 2c and d). These data show that,
in contrast to the flaky tail mutation
(Fallon et al., 2009; Oyoshi et al.,
2009), caspase-14 deficiency does not
lead to exacerbation of OVA-induced
allergic responses in mice. There was
no statistically significant difference in
dermal eosinophil infiltrates in caspase-
14 deficient-mice relative to wild-type
mice upon antigen sensitization (Figure
2e). Consequently, there was no differ-
ence in mRNA levels of the eosinophil-
homing chemokines IL-5, CCL11, and
CCL24 between the two mouse geno-
types (data not shown).
Our results show that mere impair-
ment of filaggrin degradation by loss of
caspase-14 does not reduce the inflam-
matory threshold in a murine model
for AD. Most probably, the structural
functions of the filaggrin monomer in
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Figure 1. Increased sensitivity to UVB-induced DNA damage in caspase-14-deficient epidermis is
abrogated by topical trans-urocanic acid (trans-UCA) application. Trans-UCA (200 mg) or vehicle
(75% ethanol, 25% DMSO) was applied on ex vivo newborn back skin of wild-type and caspase-14/
mice (10 generations backcrossed to BALB/c genetic background) before irradiation with 250 mJ cm2
UVB (TL 20W/12 RS lamp, Philips, major UV emission in the 280–320 nm range). One hour after
irradiation, the tissue was snap-frozen and stored. DNA was prepared from the epidermis, and the
concentration of cyclobutane pyrimidine dimers (CPDs) was determined by ELISA. The bars present the
mean±SE. Values were compared using two-way analysis of variance; only significant differences are
indicated, **Po0.01 (caspase-14þ /þ , vehicle: n¼ 4, trans-UCA: n¼ 8; caspase-14/, vehicle: n¼ 5,
trans-UCA: n¼ 11). mOD, milli OD.
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granular or cornified layers are more
essential than the filaggrin degradation
products in determining the permissive-
ness to epicutaneous sensitization. In-
deed, flaky tail mice exhibit an impaired
bidirectional barrier function, probably
due to defective lamellar body secretion
(Scharschmidt et al., 2009), which is not
the case in caspase-14-deficient mice
(Denecker et al., 2007; our unpublished
observations). Likely, this barrier ab-
normality is causing enhanced percuta-
neous allergen priming, leading to
exacerbated skin inflammation in flaky
tail mice. Our findings emphasize the
importance of normal filaggrin levels
and correct functioning of its degrading
machinery, which involves caspase-14,
for optimal protection of the skin against
harmful UVB irradiation.
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Figure 2. Similar ovalbumin (OVA)-specific immune response in caspase-14-deficient and wild-type mice. (a) May–Gru¨nwald Giemsa staining of skin sections.
(b) Epidermal thickness, and (c) total serum IgE levels. (d) Skin cytokine mRNA expression measured by quantitative reverse-transcription PCR: Th2 (IL-4 and
IL-13), Th1 (IFN-g), Th17 (IL-17), pro-inflammatory (IL-1b), and regulatory (IL-10) responses were evaluated. (e) Eosinophil density in dermis. Bars present the
mean±SE. Values were compared using two-way analysis of variance; only significant differences are indicated, **Po0.01, ***Po0.001, (caspase-14þ /þ ,
phosphate-buffered saline: n¼ 10, OVA: n¼ 13; caspase-14/, phosphate-buffered saline: n¼ 10, OVA: n¼ 13); bar¼ 50 mm.
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